Active ingredient
Octreotide acetate NDC Codes
Octreotide acetate is an active ingredient in 33 finished products listed with the FDA, under 4 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Octreotide Acetate, Octreotide, Sandostatin, BYNFEZIA Pen
- Labelers
- Fresenius Kabi USA, LLC, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Hikma Pharmaceuticals USA Inc., Gland Pharma Limited, Meitheal Pharmaceuticals, Inc., Mylan Institutional LLC, Novartis Pharmaceuticals Corporation, GLENMARK PHARMACEUTICALS INC., USA, Sun Pharmaceutical Industries, Inc., Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- Strengths
- Octreotide acetate 100 ug/mL; Octreotide acetate 500 ug/mL; Octreotide acetate 50 ug/mL; Octreotide acetate 1000 ug/mL; Octreotide acetate 200 ug/mL; Octreotide acetate 2.5 mg/mL
- Dosage forms
- Injection, Solution, Injection
- Routes
- Intravenous, Subcutaneous
- Drug classes (FDA established)
- Somatostatin Analog
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 34
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Octreotide Acetate | Octreotide acetate 50 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals, Inc. | 71288-566 | 71288-0566-02 | — |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals, Inc. | 71288-567 | 71288-0567-02 | — |
| Octreotide Acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals, Inc. | 71288-568 | 71288-0568-02 | — |
| BYNFEZIA Penoctreotide acetate | Octreotide acetate 2.5 mg/mL | InjectionSubcutaneous | Sun Pharmaceutical Industries, Inc. | 62756-452 | 62756-0452-3662756-0452-37 | — |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 52958-046 | 52958-0046-10 | — |
| Octreotide Acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | GLENMARK PHARMACEUTICALS INC., USA | 68462-897 | 68462-0897-10 | — |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | GLENMARK PHARMACEUTICALS INC., USA | 68462-896 | 68462-0896-10 | — |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Gland Pharma Limited | 68083-517 | 68083-0517-10 | — |
| Octreotide Acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Gland Pharma Limited | 68083-560 | 68083-0560-10 | — |
| Octreotide Acetate | Octreotide acetate 1000 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Gland Pharma Limited | 68083-516 | 68083-0516-01 | — |
| Octreotide Acetate | Octreotide acetate 200 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Gland Pharma Limited | 68083-515 | 68083-0515-01 | — |
| Octreotide Acetate | Octreotide acetate 1000 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-686 | 23155-0686-31 | — |
| Octreotide Acetate | Octreotide acetate 200 ug/mL | Injection, SolutionIntravenous, Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-685 | 23155-0685-31 | — |
| Octreotide Acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-689 | 23155-0689-41 | — |
| Octreotide Acetate | Octreotide acetate 50 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-687 | 23155-0687-41 | — |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-688 | 23155-0688-41 | — |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Mylan Institutional LLC | 67457-245 | 67457-0245-01 | — |
| Octreotide Acetate | Octreotide acetate 50 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Mylan Institutional LLC | 67457-239 | 67457-0239-01 | — |
| Octreotide Acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Mylan Institutional LLC | 67457-246 | 67457-0246-01 | — |
| Octreotideoctreotide acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-376 | 63323-0376-01 | — |
| Octreotideoctreotide acetate | Octreotide acetate 200 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-378 | 63323-0378-05 | — |
| Octreotideoctreotide acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-376 | 63323-0376-04 | — |
| Octreotideoctreotide acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-377 | 63323-0377-01 | — |
| Octreotideoctreotide acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-377 | 63323-0377-04 | — |
| Octreotideoctreotide acetate | Octreotide acetate 1000 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-379 | 63323-0379-05 | — |
| Octreotide Acetate | Octreotide acetate 200 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | 0641-6177 | 00641-6177-01 | — |
| Octreotide Acetate | Octreotide acetate 1000 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | 0641-6178 | 00641-6178-01 | — |
| Octreotide Acetate | Octreotide acetate 50 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | 0641-6174 | 00641-6174-10 | — |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | 0641-6175 | 00641-6175-10 | — |
| Octreotide Acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | 0641-6176 | 00641-6176-10 | — |
| Sandostatinoctreotide acetate | Octreotide acetate 50 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Novartis Pharmaceuticals Corporation | 0078-0180 | 00078-0180-01 | — |
| Sandostatinoctreotide acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Novartis Pharmaceuticals Corporation | 0078-0181 | 00078-0181-01 | — |
| Sandostatinoctreotide acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Novartis Pharmaceuticals Corporation | 0078-0182 | 00078-0182-01 | — |
Octreotide acetate: common questions
- Which drugs contain Octreotide acetate?
- Octreotide Acetate, Octreotide, Sandostatin, BYNFEZIA Pen.
- Is there a J-code for Octreotide acetate?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.